CAS 112108-01-7

(-)-(6aS,13bR)-11-Chloro-12-hydroxy-7-methyl-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphtho[2,1-d]azepine

Description:

The chemical substance known as "(-)-(6aS,13bR)-11-Chloro-12-hydroxy-7-methyl-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphtho[2,1-d]azepine" with the CAS number 112108-01-7 is a complex organic compound characterized by its unique bicyclic structure, which includes a benzo[d]naphtho[2,1-d]azepine framework. This compound features several functional groups, including a chlorine atom and a hydroxyl group, which contribute to its chemical reactivity and potential biological activity. The stereochemistry indicated by the specific configuration at the 6a and 13b positions suggests that it may exhibit chiral properties, influencing its interactions in biological systems. Such compounds are often of interest in medicinal chemistry due to their potential pharmacological effects. The presence of multiple rings and substituents may also affect its solubility, stability, and overall behavior in various chemical environments. Further studies would be necessary to elucidate its specific applications and mechanisms of action.

Formula: C₁₉H₂₁Cl₂NO

InChI: InChI=1/C19H20ClNO.ClH/c1-21-9-8-13-10-16(20)18(22)11-15(13)19-14-5-3-2-4-12(14)6-7-17(19)21;/h2-5,10-11,17,19,22H,6-9H2,1H3;1H/t17-,19+;/m0./s1

InChI key: InChIKey=DMJWENQHWZZWDF-PKOBYXMFSA-N

SMILES: CN1[C@@]2([C@@](C=3C(=CC(Cl)=C(O)C3)CC1)(C=4C(CC2)=CC=CC4)[H])[H]

Synonyms:

• (6aS,13bR)-11-Chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5H-benzo[d]naphth[2,1-b]azepin-12-ol
• (6aS,13bR)-11-chloro-7-methyl-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphtho[2,1-b]azepin-12-ol
• (6aS,13bR)-11-chloro-7-methyl-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphtho[2,1-b]azepin-12-ol hydrochloride (1:1)
• 5H-Benzo[d]naphth[2,1-b]azepin-12-ol, 11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-, (6aS,13bR)-
• 5H-Benzo[d]naphth[2,1-b]azepin-12-ol, 11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-, (6aS-trans)-
• Ecopipam
• Psyrx 101
• Sch-39166
• ECOPIPAM(6 AS,13 BR)-FORM
• (6aβ,13bα)-11-Chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5H-benzo[d]naphth[2,1-b]azepin-12-ol
• Unii-0X748o646k
• Ecopipam [inn]
• 6,7,7A,8,9,13B-Hexahydro-3-chloro-2-hydroxy-N-methyl-5H-benzo(D)naphtho(2,1B)azepine
• Ecopipam-d4
• (-)-(6aS,13bR)-11-Chloro-12-hydroxy-7-methyl-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphtho[2,1-d]azepine
• (6aS)-11-Chloro-6,6aβ,7,8,9,13bα-hexahydro-7-methyl-5H-benzo[d]naphth[2,1-b]azepin-12-ol
• [13C6]-Ecopipam

Ecopipam

CAS: 112108-01-7

Ecopipam

Purity: ≥98%

Molecular weight: 313.82g/mol

Ref: 54-BUP11564

Ecopipam

CAS: 112108-01-7

Formula: C₁₉H₂₀ClNO

Molecular weight: 313.82

Ref: 7W-GP0063

Ecopipam

CAS: 112108-01-7

Ecopipam: orally active, selective dopamine D1/D5 antagonist (Ki: 1.2 nM/2.0 nM). 40x more selective over D2/D4/5-HT/α2a. For schizophrenia, obesity research.

Formula: C₁₉H₂₀ClNO

Purity: 99.68%

Color and Shape: Solid

Molecular weight: 313.82

Ref: TM-T31602

Ecopipam

CAS: 112108-01-7

Ecopipam is an antagonist drug that blocks the 5-HT2A receptor. It has been shown to have a high affinity for this receptor, and it is one of the most potent antagonists in its class. Ecopipam has been shown to cause a reduction in locomotor activity in rats when administered at low doses and to inhibit brain functions such as dopamine release, although these effects are not observed at higher doses. This drug also has side-effects such as drowsiness and sedation, which may be due to its effect on brain function. Ecopipam does not seem to have any significant interactions with other drugs, and is therefore safe for use in combination with other drugs.

Formula: C₁₉H₂₀ClNO

Purity: Min. 95%

Molecular weight: 313.82 g/mol

Ref: 3D-FE159526